Genmab Technical Analysis

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>GA</div>
GMAB -- Denmark Stock  

DKK 2,028  53.00  2.68%

As of the 25th of May Genmab AS retains Market Risk Adjusted Performance of 4.0, Downside Deviation of 4.34 and Risk Adjusted Performance of 0.4525. Genmab AS technical analysis makes it possible for you to employ historical prices and volume momentum with intention to determine a pattern that calculates the direction of the corporation future prices. Simply put, you can use this information to find out if the corporation will indeed mirror its model of historical price patterns or the prices will eventually revert. We found nineteen technical drivers for Genmab AS, which can be compared to its competitors. Please check out Genmab AS Standard Deviation, Information Ratio, Treynor Ratio, as well as the relationship between Variance and Jensen Alpha to decide if Genmab AS is priced fairly providing market reflects its last-minute price of 2028.0 per share.

Search Technical Analysis

 
Refresh

Genmab AS Technical Analysis

Indicator
Time Period
  Portfolio Suggestion    
  
Execute Indicator
 
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Genmab AS volatility. High ATR values indicate high volatility, and low values indicate low volatility. View also all equity analysis or get more info about average true range volatility indicators indicator.

Genmab AS Trend Analysis

Use this graph to draw trend lines for Genmab AS. You can use it to identify possible trend reversals for Genmab AS as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Genmab AS price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Genmab AS Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Genmab AS applied against its price change over selected period. The best fit line has a slop of   7.50  which means Genmab AS will continue producing value for investors. It has 122 observation points and a regression sum of squares at 2125830.28, which is the sum of squared deviations for the predicted Genmab AS price change compared to its average price change.

About Genmab AS Technical Analysis

The Macroaxis Technical Analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Genmab AS on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Genmab AS based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Genmab AS stock first instead of the macroeconomic environment surrounding Genmab AS. By analyzing Genmab AS's financials, daily price indicators, and its related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Genmab AS's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Genmab AS specific price patterns or momentum indicators. Please read more on our technical analysis page.

Genmab AS May 25, 2020 Technical Indicators

Please check Risk vs Return Analysis. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page